One decade of meningitis cases in Paraná State, Brazil: study of cases in the pre- and post-vaccinal period
DOI:
https://doi.org/10.47456/rbps.v22i2.31609Keywords:
Meningitis, Pneumococcal Meningitis, Meningococcal Meningitis, VaccinesAbstract
Introduction: Meningitis is an inflammatory process capable of affecting the central nervous system in humans; thus, it is a global public health issue. Objectives: Describing meningitis epidemiology in Paraná State, Brazil, as well as the impact of introducing conjugate vaccines (pneumococcal and meningococcal) in the immunization schedule. Methods: Retrospective, observational and descriptive study about notified and confirmed meningitis cases in Paraná State. Data were organized in pre- (2007 to 2009) and post-introduction (2010 to 2016) of meningococcal C and 10-valent pneumococcal vaccines. Results: In total, 17,045 meningitis cases were confirmed in Paraná State from 2007 to 2016 - 2007 was the year recording the largest number of cases (n=3,489). Most notified cases were diagnosed in men (59.1%) and mostly affected patients in the age group 0-to-9-years. Aseptic meningitis (viral) was the most often diagnosed type of the disease among meningitis with known etiology; it was followed by Neisseria meningitidis, Streptococcus pneumoniae, Mycobacterium tuberculosis and Haemophilus influenzae. Neisseria meningitidis serogroup C was the most common type; it was followed by serogroup B. There was significant decrease in the frequency of N. meningitidis and S. pneumoniae in 1-to-4-year-old children, after vaccination. Conclusion: Vaccine-preventable bacterial meningitis rate has decreased in Paraná State, mainly due to the introductionof conjugate vaccines. Understanding meningitis etiology is a key factor to measuments taken by epidemiological surveillance to prevent and control the diseaseand, consequently, to help improving public health.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Revista Brasileira de Pesquisa em Saúde/Brazilian Journal of Health Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Revista Brasileira de Pesquisa em Saúde (RBPS) adopts the CC BY 4.0 license, which means that authors retain the copyright of the works they submit to the journal. Authors are responsible for declaring that their contribution is an original manuscript, that it has not been previously published, and that it is not under simultaneous review by another scientific journal. Upon submitting the manuscript, authors grant RBPS the exclusive right of first publication, subject to peer review.
Authors are permitted to enter into additional contracts for the non-exclusive distribution of the version published by RBPS (for example, in institutional repositories or as a book chapter), provided that due acknowledgment of authorship and of initial publication by RBPS is given. Authors are also encouraged to make their work available online (for example, in institutional repositories or on their personal pages) after its initial publication in the journal, with due acknowledgment of authorship and of the original publication by RBPS.
Accordingly, under the CC BY 4.0 license, readers have the right to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially;
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
